[Alarming data on the risk of breast cancer following estrogen replacement therapy should be interpreted carefully].
Odlind
Viveca
V
Läkemedelsverket, Uppsala. viveca.odlind@mpa.se
D001943:Breast Neoplasms / Q000139:chemically induced* / Q000453:epidemiology; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D018570:Risk Assessment; D012307:Risk Factors; D013548:Sweden / Q000453:epidemiology